| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.084 | 0.007 |